Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid vs placebo in glucocorticoid-treated osteoporotic children
2008-001252-52Phase 3Terminated
- Sponsor
- Novartis
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis comparing Zoledronic acid arm with Placebo arm (2 arms). Primary endpoint: Lumbar spine areal BMD Z-score change. Started Oct 2008; status: terminated.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2008-001252-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001252-52.